Tuesday, October 20, 2026 | UTC
About | Contact | API Status
Sign In Subscribe
Live
AAPL $342.94 -0.15%
MSFT $533.52 +0.84%
GOOGL $344.18 +1.05%
AMZN $262.45 +4.98%
TSLA $368.06 +3.76%
META $705.44 -0.55%
NVDA $217.09 +1.38%
JPM $333.53 -1.82%
BTC $36.14 +0.31%
ETH $22.81 -0.74%
Latest Signing ceremony for contribution agreements between WHO and France Oct 17, 2024
AAPL
$342.94
▼ 0.15%
MSFT
$533.52
▲ 0.84%
GOOGL
$344.18
▲ 1.05%
AMZN
$262.45
▲ 4.98%
TSLA
$368.06
▲ 3.76%
META
$705.44
▼ 0.55%
NVDA
$217.09
▲ 1.38%
JPM
$333.53
▼ 1.82%

Top Stories

Markets →
All Markets Technology Economy Science Health Sports Entertainment Politics
Science Daily
Semaglutide (Ozempic) linked to fewer bone fractures despite greater weight loss
A large real-world study suggests semaglutide (Ozempic, Wegovy, Rybelsus) may offer an unexpected bonus for people with type 2 diabetes: stronger protection against bone fractures while delivering greater weight loss. Researchers analyzing health records from nearly 60,000 adults found that people taking semaglutide experienced about 15% fewer fractures than those using other common weight-loss medications, despite losing more weight.
science  Jun 16, 2026
Variety
Content Partners Secures Fresh Round of Funding From Carlyle Global Credit
Content Partners has struck a new deal with Carlyle Global Credit to facilitate fresh investment capital for the company that has been a pioneer in buying out ownership stakes and profit participation rights in movies and TV shows from individuals and production companies. Investment giant Carlyle owns the majority of Los Angeles-based Content Partners, which […]
entertainment  Jun 16, 2026

Stay ahead of the markets.

Get free access to breaking news, stock data, and market analysis.

Subscribe Free